Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Aug;100(4):786–792. doi: 10.1111/j.1476-5381.1990.tb14093.x

Relationship between endothelin-1 binding site densities and constrictor activities in human and animal airway smooth muscle.

P J Henry 1, P J Rigby 1, G J Self 1, J M Preuss 1, R G Goldie 1
PMCID: PMC1917571  PMID: 2169940

Abstract

1. Endothelin-1 (ET-1) binding site densities and constrictor activities were compared in airway smooth muscle preparations of human, guinea-pig, rat and mouse. 2. The mean contractile response to 0.3 microM ET-1 (measured as the % maximum response to 10 microM carbachol, % Cmax +/- s.e.mean) and the mean concentration of ET-1 producing 30% Cmax (95% confidence limits) were respectively; 85.9 +/- 5.4% and 3.4 nM (2.4-5.0) for mouse trachea (n = 11), 88.8 +/- 4.7% and 18.2 nM (11.2-25.2) for rat trachea (n = 6), 71.0 +/- 7.1% and 35.2 nM (5.4-231) for human bronchus (n = 3), and 32.3 +/- 3.0% and 241 nM (125-460) for guinea-pig trachea (n = 6). 3. Light microscopic autoradiography revealed specific [125I]-ET-1 binding sites localized to the smooth muscle band, with very low levels of binding associated with cartilage, submucosal and epithelial cells. 4. Quantitative autoradiographic analyses of the concentration-dependence of specific [125I]-ET-1 binding (0.1-2 nM) to smooth muscle revealed similar dissociation constants but markedly different specific binding site densities for the various animal species. The order of densities of specific [125I]-ET-1 binding sites was rat trachea (69.0 +/- 11.2 amol mm-2) greater than human bronchus (42.7 +/- 17.5 amol mm-2) greater than mouse trachea (28.7 +/- 2.6 amol mm-2) greater than guinea-pig trachea (8.3 +/- 1.8 amol mm-2). 5. A positive relationship between [125I]-ET-1 binding site density and ET-1 constrictor activity was observed in airway smooth muscle preparations from rat, human and guinea-pig.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
786

Images in this article

789Figure 5
on p.789
790Figure 6
on p.790

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borges R., Von Grafenstein H., Knight D. E. Tissue selectivity of endothelin. Eur J Pharmacol. 1989 Jun 20;165(2-3):223–230. doi: 10.1016/0014-2999(89)90716-4. [DOI] [PubMed] [Google Scholar]
  2. Braquet P., Touvay C., Lagente V., Vilain B., Pons F., Hosford D., Chabrier P. E., Mencia-Huerta J. M. Effect of endothelin-1 on blood pressure and bronchopulmonary system of the guinea pig. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S143–S150. doi: 10.1097/00005344-198900135-00036. [DOI] [PubMed] [Google Scholar]
  3. D'Orleans-Juste P., Finet M., de Nucci G., Vane J. R. Pharmacology of endothelin-1 in isolated vessels: effect of nicardipine, methylene blue, hemoglobin, and gossypol. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S19–S45. [PubMed] [Google Scholar]
  4. Eglen R. M., Michel A. D., Sharif N. A., Swank S. R., Whiting R. L. The pharmacological properties of the peptide, endothelin. Br J Pharmacol. 1989 Aug;97(4):1297–1307. doi: 10.1111/j.1476-5381.1989.tb12592.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goldie R. G., Spina D., Henry P. J., Lulich K. M., Paterson J. W. In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline. Br J Clin Pharmacol. 1986 Dec;22(6):669–676. doi: 10.1111/j.1365-2125.1986.tb02956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Henry P. J., Rigby P. J., Goldie R. G. Distribution of beta 1- and beta 2-adrenoceptors in mouse trachea and lung: a quantitative autoradiographic study. Br J Pharmacol. 1990 Jan;99(1):136–144. doi: 10.1111/j.1476-5381.1990.tb14667.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hirata Y., Takagi Y., Fukuda Y., Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis. 1989 Aug;78(2-3):225–228. doi: 10.1016/0021-9150(89)90227-x. [DOI] [PubMed] [Google Scholar]
  8. Maggi C. A., Patacchini R., Giuliani S., Meli A. Potent contractile effect of endothelin in isolated guinea-pig airways. Eur J Pharmacol. 1989 Jan 24;160(1):179–182. doi: 10.1016/0014-2999(89)90670-5. [DOI] [PubMed] [Google Scholar]
  9. Neuser D., Steinke W., Theiss G., Stasch J. P. Autoradiographic localization of [125I]endothelin-1 and [125I]atrial natriuretic peptide in rat tissue: a comparative study. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S67–S74. doi: 10.1097/00005344-198900135-00016. [DOI] [PubMed] [Google Scholar]
  10. Payne A. N., Whittle B. J. Potent cyclo-oxygenase-mediated bronchoconstrictor effects of endothelin in the guinea-pig in vivo. Eur J Pharmacol. 1988 Dec 13;158(3):303–304. doi: 10.1016/0014-2999(88)90085-4. [DOI] [PubMed] [Google Scholar]
  11. Power R. F., Wharton J., Zhao Y., Bloom S. R., Polak J. M. Autoradiographic localization of endothelin-1 binding sites in the cardiovascular and respiratory systems. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S50–S74. doi: 10.1097/00005344-198900135-00013. [DOI] [PubMed] [Google Scholar]
  12. Reep R. L., Creegan W. J. An accurate method for automated counting of silver grains in autoradiographs. Comput Biomed Res. 1988 Jun;21(3):244–267. doi: 10.1016/0010-4809(88)90031-6. [DOI] [PubMed] [Google Scholar]
  13. Sakata K., Ozaki H., Kwon S. C., Karaki H. Effects of endothelin on the mechanical activity and cytosolic calcium level of various types of smooth muscle. Br J Pharmacol. 1989 Oct;98(2):483–492. doi: 10.1111/j.1476-5381.1989.tb12621.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Secrest R. J., Cohen M. L. Endothelin: differential effects in vascular and nonvascular smooth muscle. Life Sci. 1989;45(15):1365–1372. doi: 10.1016/0024-3205(89)90023-4. [DOI] [PubMed] [Google Scholar]
  15. Turner N. C., Power R. F., Polak J. M., Bloom S. R., Dollery C. T. Endothelin-induced contractions of tracheal smooth muscle and identification of specific endothelin binding sites in the trachea of the rat. Br J Pharmacol. 1989 Oct;98(2):361–366. doi: 10.1111/j.1476-5381.1989.tb12605.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Uchida Y., Ninomiya H., Saotome M., Nomura A., Ohtsuka M., Yanagisawa M., Goto K., Masaki T., Hasegawa S. Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor. Eur J Pharmacol. 1988 Sep 13;154(2):227–228. doi: 10.1016/0014-2999(88)90106-9. [DOI] [PubMed] [Google Scholar]
  17. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES